Long-lived proteins such as collagen, are partially or wholly modified in their molecular structure by glycation, resulting in accumulation of aminoketoses and formation of advanced Maillard reaction products, also known as advanced glycation end products (AGEs). Pyrraline, one of the major AGEs, is formed via a non-enzymatic reaction between reducing sugar and the epsilon-amino group of lysine residues of proteins, 1) and is thought to cause damage to tissues.2) AGE formation pathways are believed to consist of two types; one requires oxidative conditions (glycoxidation) and the other non-oxidative conditions. Pentosidine is a product of the former pathway [3][4][5][6] and pyrraline is a product of the latter pathway.
7)A previous study demonstrated by immunological methods that the pyrraline level is increased in diabetic sclerosed arterial and extracellular matrix, as well as in the sclerosed matrix of glomeruli.8) Another study also demonstrated by electrospray ionization (ESI) mass spectrometric detection an increase in pyrraline level of the plasma from uremic subjects.9) The level of plasma 3-deoxyglucosone, 10,11) an intermediate product in pyrraline and pentosidine formation, has been reported to increase in diabetic 12,13) and in uremic individuals.
14)Recently, chromatographic methods were applied in the measurement of the urinary level of pyrraline, and its increase in diabetic patients was demonstrated, 15,16) suggesting usefulness of the methods for evaluation of diabetic complications. However, there are few other reports describing chromatographic techniques for determination of pyrraline levels in biological fluids. In this paper, we describe development of a rapid and accurate method for the determination of urinary pyrraline using solid-phase extraction prior to separation and analysis by HPLC. Moreover, the proposed method was applied to analysis of urine samples obtained from healthy volunteers.
MATERIALS AND METHODSChemicals L-Lysine, D-glucose, acetonitrile (HPLC grade) and trifluoroacetic acid (for amino acid sequencing analysis; TFA) were purchased from Wako Pure Chemical Ind., Ltd. (Tokyo, Japan) and used without further purification. The solid-phase extraction cartridge, Oasis TM HLB (3 ml, Waters Co., MA, U.S.A.), was used for pretreatment of urine samples. Other reagents obtained from commercial suppliers were of special reagent grade and/or analytical grade.Preparation of Pyrraline Standard Standard pyrraline was synthesized and purified, with some modifications, according to the method of Nakayama et al.1) L-Lysine (6.60 g) and D-glucose (8.10 g) were dissolved in 100 ml of 0.5 M sodium phosphate buffer (pH 8.5). The mixture was maintained at 80°C for 2 d, and then cooled. The cooled reactant was loaded onto a gel-filtration column (50ϫ1000 mm, Bio Gel P-2, 45-90 mm, Bio-Rad Labs., CA, U.S.A.) using 10% (w/v) acetic acid as the elution solvent at a flow rate of 36 ml/h. The absorbance at 298 nm of each fraction (16 ml/tube) was determined, and the fractions containing pyrraline wer...